Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Publication year range
1.
Clin Transl Oncol ; 22(12): 2364-2368, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32449128

ABSTRACT

BACKGROUND: There are no large reported series determining the Covid-19 cancer patient's characteristics. We determine whether differences exist in cumulative incidence and mortality of Covid-19 infection between cancer patients and general population in Madrid. MATERIAL AND METHODS: We reviewed 1069 medical records of all cancer patients admitted at Oncology department between Feb 1 and April 7, 2020. We described Covid-19 cumulative incidence, treatment outcome, mortality, and associated risk factors. RESULTS: We detected 45/1069 Covid-19 diagnoses in cancer patients vs 42,450/6,662,000 in total population (p < 0.00001). Mortality rate: 19/45 cancer patients vs 5586/42,450 (p = 0.0001). Mortality was associated with older median age, adjusted by staging and histology (74 vs 63.5 years old, OR 1.06, p = 0.03). Patients who combined hydroxychloroquine and azithromycin presented 3/18 deaths, regardless of age, staging, histology, cancer treatment and comorbidities (OR 0.02, p = 0.03). CONCLUSION: Cancer patients are vulnerable to Covid-19 with an increase in complications. Combined hydroxychloroquine and azithromycin is presented as a good treatment option.


Subject(s)
Coronavirus Infections/complications , Coronavirus Infections/mortality , Neoplasms/complications , Neoplasms/epidemiology , Pneumonia, Viral/complications , Pneumonia, Viral/mortality , Aged , Azithromycin/therapeutic use , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus Infections/diagnosis , Coronavirus Infections/drug therapy , Drug Combinations , Female , Humans , Hydroxychloroquine/therapeutic use , Incidence , Male , Middle Aged , Neoplasms/pathology , Pandemics , Pneumonia, Viral/diagnosis , Pneumonia, Viral/drug therapy , Risk Factors , SARS-CoV-2 , Spain/epidemiology , Treatment Outcome
4.
Clin. transl. oncol. (Print) ; 12(3): 238-239, mar. 2010. ilus
Article in English | IBECS | ID: ibc-124064

ABSTRACT

The mucosal metastasis of adenocarcinomas located in colonic mucosa is not infrequent. We present a clinical report of a patient diagnosed with a gastric multifocal signet ring cell adenocarcinoma without any evidence of visceral dissemination with the exception of mucosal infiltration of signet ring cell adenocarcinoma in a colonic polyp and in the mucosa of previous colonic anastomosis. The histopathological study of suspect lesions in the colonic mucosa is necessary to correctly approach the treatment of these patients (AU)


No disponible


Subject(s)
Humans , Male , Aged, 80 and over , Anastomosis, Surgical/methods , Carcinoma, Signet Ring Cell/secondary , Colonic Polyps/pathology , Hypertension, Pulmonary/complications , Colorectal Neoplasms/secondary , Neoplasms, Second Primary/pathology , Stomach Neoplasms/complications , Stomach Neoplasms/pathology , Adenocarcinoma/pathology , Adenocarcinoma/surgery , Carcinoma, Signet Ring Cell/complications , Colorectal Neoplasms/complications , Diabetes Mellitus, Type 2/complications , Idiopathic Pulmonary Fibrosis/complications , Renal Insufficiency, Chronic/complications , Myocardial Ischemia/complications , Sigmoid Neoplasms/pathology , Sigmoid Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...